Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

dmt clinical trials

SPL026 Small Pharma (DMT.V), a psychedelics company focusing on DMT announced today it’s completed Phase 1 for its drug candidate SPL026, (a DMT derivative) for the treatment of Major…
New clinical trials are emerging in the psychedelics sector at a rapid pace. Several compounds are being studied for their efficacy in treating ailments like PTSD, depression, anxiety, and…
SPL026   Small Pharma (DMT.V) is a London-based psychedelics company focusing on DMT-assisted psychotherapy for depression, and they’re already doing Phase 1 clinical trials, with Phase 2 on the…